| dc.contributor | Consorci Sanitari de Terrassa |
| dc.contributor.author | Fernández-Cidón, Bárbara |
| dc.contributor.author | Candás-Estébanez, Beatriz |
| dc.contributor.author | Gil, Miriam |
| dc.contributor.author | Amigó, Núria |
| dc.contributor.author | Corbella, Emili |
| dc.contributor.author | Rodríguez Sánchez, Maria de los Ángeles |
| dc.contributor.author | Mauri Pont, Marta |
| dc.date.accessioned | 2023-09-29T11:45:37Z |
| dc.date.available | 2023-09-29T11:45:37Z |
| dc.date.issued | 2021-03-29 |
| dc.identifier.citation | Fernández-Cidón B, Candás-Estébanez B, Gil-Serret M, Amigó N, Corbella E, Rodríguez-Sánchez MA, et al. Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study. J Clin Med. 2021 Mar 29;10(7):1379. |
| dc.identifier.uri | https://hdl.handle.net/11351/10380 |
| dc.description | Cardiovascular diseases; Lipoproteins; Magnetic resonance spectroscopy |
| dc.description.abstract | Some lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) are not detected by the conventional lipid profile. In this case-control study, the predictive power of PCVD of serum sdLDL-C, measured using a lipoprotein precipitation method, and of the physicochemical properties of serum lipoproteins, analyzed by nuclear magnetic resonance (NMR) techniques, were evaluated. We studied a group of patients with a first PCVD event (n = 125) and a group of control subjects (n = 190). Conventional lipid profile, the size and number of Very Low Density Lipoproteins (VLDL), Low Density Lipoproteins (LDL), High Density Lipoproteins (HDL) particles, and the number of particles of their subclasses (large, medium, and small) were measured. Compared to controls, PCVD patients had lower concentrations of all LDL particles, and smaller and larger diameter of LDL and HDL particles, respectively. PCVD patients also showed higher concentrations of small dense LDL-cholesterol (sdLDL), and triglycerides (Tg) in LDL and HDL particles (HDL-Tg), and higher concentrations of large VLDL particles. Multivariate logistic regression showed that sdLDL-C, HDL-Tg, and large concentrations of LDL particles were the most powerful predictors of PCVD. A strong relationship was observed between increased HDL-Tg concentrations and PCVD. This study demonstrates that beyond the conventional lipid profile, PCVD patients have other atherogenic lipoprotein alterations that are detected by magnetic resonance imaging (MRI) analysis. |
| dc.language.iso | eng |
| dc.publisher | MDPI |
| dc.relation.ispartofseries | Journal of Clinical Medicine;10(7) |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Sistema cardiovascular - Malalties |
| dc.subject | Lipoproteïnes |
| dc.subject | Espectroscòpia de ressonància magnètica nuclear |
| dc.subject.mesh | Cardiovascular Diseases |
| dc.subject.mesh | Lipoproteins |
| dc.subject.mesh | Magnetic Resonance Spectroscopy |
| dc.title | Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3390/jcm10071379 |
| dc.subject.decs | enfermedades cardiovasculares |
| dc.subject.decs | lipoproteínas |
| dc.subject.decs | espectroscopia de resonancia magnética |
| dc.relation.publishversion | https://doi.org/10.3390/jcm10071379 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.authoraffiliation | [Fernández-Cidón B] Bioquímica Especial y Biología Molecular, Laboratori Clínic, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Spain. [Candás-Estébanez B] Bioquímica Especial y Biología Molecular, Laboratori Clínic, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Spain. Clinical Laboratory, SCIAS-Hospital de Barcelona, Barcelona, Spain. [Gil-Serret M] Biosfer Teslab, Reus, Spain. [Amigó N] Biosfer Teslab, Reus, Spain. CIBERDEM, Universidad Rovira i Virgili, Tarragona, Spain. [Corbella E] Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge-IDIBELL, Barcelona, Spain. Centro de Investigación Biomédica en Red, Fisiopatologia de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain. [Rodríguez-Sánchez MA] Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge, Barcelona, Spain. [Mauri M] Servei de Medicina Interna, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain |
| dc.identifier.pmid | 33805580 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |